ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 682

$1.79M Total Retail Price of All Prescriptions

Rank: 18 out of 682

498 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 21,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 810 743 1 3
FUROSEMIDE 786 682 2 7
NAMENDA 724 688 3 41
AMLODIPINE BESYLATE 655 572 4 6
WARFARIN SODIUM 629 519 5 13
HYDROCODONE-ACETAMINOPHEN 622 490 S3 6 1
OMEPRAZOLE 569 476 7 5
MIRTAZAPINE 488 418 8 52
LISINOPRIL 465 370 9 2
METOPROLOL TARTRATE 445 361 10 10
PRAVASTATIN SODIUM 440 342 11 15
DONEPEZIL HCL 439 415 12 30
ESCITALOPRAM OXALATE 423 341 13 73
EXELON 369 349 14 104
GABAPENTIN 367 248 15 9
QUETIAPINE FUMARATE 365 308 16 87
TRAZODONE HCL 335 274 17 38
DIVALPROEX SODIUM 319 265 18 84
LACTULOSE 302 246 19 100
SIMVASTATIN 300 279 20 4
POLYETHYLENE GLYCOL 3350 284 206 21 44
BYSTOLIC 274 208 22 118
HYDROCHLOROTHIAZIDE 266 213 23 12
ATORVASTATIN CALCIUM 262 195 24 11
CLOPIDOGREL 261 201 25 25
CITALOPRAM HBR 258 210 26 17
POTASSIUM CHLORIDE 234 204 27 14
TRAMADOL HCL 218 180 28 26
RISPERIDONE 216 187 29 82
NYSTATIN 210 191 30 95
LANTUS 210 144 30 55
FAMOTIDINE 194 156 32 99
INSULIN SYRINGE 194 121 32 75
CARVEDILOL 190 170 34 23
CRESTOR 181 159 35 22
SERTRALINE HCL 180 167 36 24
RANITIDINE HCL 180 164 36 28
PLAVIX 169 144 38 35
SEROQUEL 159 126 39 193
NOVOLOG 158 140 40 129
ZOLPIDEM TARTRATE 156 109 41 21
METFORMIN HCL 154 121 42 8
AMOX TR-POTASSIUM CLAVULANATE 154 126 42 110
LEXAPRO 152 134 44 222
GLIPIZIDE 146 121 45 61
BENICAR 146 119 45 202
MUPIROCIN 144 107 47 166
MELOXICAM 135 110 48 27
ROPINIROLE HCL 129 104 49 71
LEVOFLOXACIN 129 100 49 70
KLOR-CON M20 128 116 51 67
FLUTICASONE PROPIONATE 127 91 52 36
METOPROLOL SUCCINATE 122 87 53 16
NEXIUM 121 92 54 19
DIOVAN 120 102 55 42
ADVAIR DISKUS 118 100 56 47
LIDODERM 118 93 56 134
METOCLOPRAMIDE HCL 113 109 58 111
ALLOPURINOL 111 102 59 32
ISOSORBIDE MONONITRATE ER 108 108 60 31
DIGOXIN 108 97 60 46
PROMETHAZINE HCL 108 80 R 60 54
AZOR 105 81 63 340
AZITHROMYCIN 102 81 64 39
SPIRIVA 101 79 65 49
PHENYTOIN 99 67 66 265
IPRATROPIUM-ALBUTEROL 97 91 67 139
CLONIDINE HCL 96 81 68 48
ATENOLOL 94 94 69 18
TRICOR 93 91 70 94
LEVETIRACETAM 92 64 71 125
DETROL LA 92 64 71 226
COMBIVENT 88 72 73 105
PANTOPRAZOLE SODIUM 88 71 73 29
VENLAFAXINE HCL ER 85 82 75 119
CELEBREX 85 69 75 80
LIDOCAINE HCL 85 77 75 266
TAMSULOSIN HCL 83 64 78 33
ALBUTEROL SULFATE 82 77 79 156
EVISTA 81 81 80 135
PREDNISONE 79 64 81 40
ENABLEX 78 62 82 274
VENLAFAXINE HCL 78 22 82 225
LOPERAMIDE 76 65 84 253
RAMIPRIL 76 76 84 81
TOPIRAMATE 76 33 84 150
SUCRALFATE 75 52 87 160
BENICAR HCT 72 61 88 259
FENTANYL 72 64 S2 88 86
FINASTERIDE 71 53 90 131
VALPROIC ACID 71 33 90 262
JANUVIA 70 67 92 62
ONDANSETRON HCL 70 51 92 195
OXYBUTYNIN CHLORIDE ER 70 39 92 180
CARBIDOPA-LEVODOPA 70 70 92 121
CEPHALEXIN 69 52 96 128
FLUOXETINE HCL 67 40 97 60
BISOPROLOL FUMARATE 66 57 98 142
ENOXAPARIN SODIUM 65 62 99 215
ACTONEL 64 61 100 281
CEFTRIAXONE 63 55 101 261
CIPROFLOXACIN HCL 62 49 102 58
CYCLOBENZAPRINE HCL 61 38 R 103 65
CYMBALTA 61 40 103 51
OLANZAPINE 60 48 105 168
TRIBENZOR 60 58 105 439
IPRATROPIUM BROMIDE 59 58 107 212
KLOR-CON M10 58 56 108 186
LYRICA 57 37 109 78
OXYCODONE-ACETAMINOPHEN 57 46 S2 109 120
SPIRONOLACTONE 55 32 111 64
WELCHOL 55 44 111 232
IBUPROFEN 54 45 113 79
GLYBURIDE 53 52 R 114 72
NOVOLIN R 53 44 114 167
TEKTURNA 53 36 114 243
DILANTIN 53 37 114 322
SINGULAIR 52 44 118 63
DOXYCYCLINE HYCLATE 52 43 118 137
METHYLPREDNISOLONE 50 47 120 127
ALENDRONATE SODIUM 50 33 120 37
DILTIAZEM 24HR CD 50 50 120 123
VESICARE 50 50 120 240
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 43 120 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.